The GLP is committed to full transparency. Download and review our 2019 Annual Report
Scientists are working with treatments that have shown success in amping up the metabolism of mice, helping them lose weight and exercise longer.
“How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?”
The narrative of underdog cancer victims unmasking corporate villains isn’t backed up by the evidence.
Paul Offit has forged a second career as an influential spokesman for scientific thinking.
The unsatisfactory answer to ‘How do we control the spread of disinformation?” may be, “We don’t know yet.”
Bad research can put people’s lives at risk, so addressing problems with peer review is essential.
On this episode of Biotech Facts and Fallacies, Tim Lu talks to Cameron English about Senti’s progress toward “outsmarting complex diseases with more intelligent medicines.”
Seeing what has happened to Golden Rice over the course of 20 years, nothing would surprise me going forward.
Impossible Foods has enthusiastically defended its use of genetic engineering to produce meat substitutes.
Scientists are generally inclined to dislike big companies–but they know that biotechnology has made our food supply safer and more sustainable, writes Cameron English.
While the GMO controversy rages, a handful of companies are taking another innovative approach to crop protection.
Anti-GMO activists should take a step back and look closely at some of the benefits that new genetically modified crops offer for humans and the environment.
“Natural food” advocates have blasted Impossible and Beyond as unhealthy. Let’s look at their arguments.